MedTrace Logo

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

NCT03584958 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-03-29

No results posted yet for this study

Summary

The primary goal of this study is to evaluate refractive and visual outcomes in glaucoma patients who will be having either traditional glaucoma surgery or minimally invasive glaucoma surgery, also known as MIGS.

Conditions

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • The American Society of Cataract and Refractive Surgery Foundation

    collaborator OTHER

  • Wills Eye

    lead OTHER

Principal Investigators

  • Daniel Lee, MD · Wills Eye Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03584958 on ClinicalTrials.gov